IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
0.750
+0.060 (8.70%)
At close: Mar 6, 2026, 4:00 PM EST
0.720
-0.030 (-3.96%)
After-hours: Mar 6, 2026, 6:27 PM EST
Company Description
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.
It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands.
The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.
IM Cannabis Corp.
| Country | Israel |
| Founded | 1980 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 95 |
| CEO | Oren Shuster |
Contact Details
Address: Kibbutz Glil Yam, Central District Tel Aviv, 4690500 Israel | |
| Website | imcannabis.com |
Stock Details
| Ticker Symbol | IMCC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| CIK Code | 0001792030 |
| CUSIP Number | 44969Q208 |
| ISIN Number | CA44969Q4060 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Eyal Fisher | Chief Executive Officer of the IMC Holdings |
| Richard Balla | Chief Executive Officer of Adjupharm |
| Oren Shuster | Chief Executive Officer and Executive Director |
| Advocate Michal Lebovitz Nissimov | General Counsel and Secretary |
| Asi Levi | Chief Financial Officer |
| Anna Taranko | Director Investor and Public Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 11, 2026 | EFFECT | Notice of Effectiveness |
| Feb 5, 2026 | F-3 | Filing |
| Jan 26, 2026 | 6-K | Report of foreign issuer |
| Jan 5, 2026 | 6-K | Report of foreign issuer |
| Dec 30, 2025 | 6-K | Report of foreign issuer |
| Dec 12, 2025 | 6-K | Report of foreign issuer |
| Nov 17, 2025 | 6-K | Report of foreign issuer |
| Nov 13, 2025 | 6-K | Report of foreign issuer |
| Nov 6, 2025 | 6-K | Report of foreign issuer |
| Oct 29, 2025 | 6-K | Report of foreign issuer |